{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:21:14Z","timestamp":1789017674140,"version":"build-2803163510"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>von Willebrand disease (VWD) is the most common inherited bleeding disorder. The management of patients with VWD who are undergoing surgeries is crucial to prevent bleeding complications. We systematically summarized the evidence on the management of patients with VWD who are undergoing major and minor surgeries to support the development of practice guidelines. We searched Medline and EMBASE from inception through October 2019 for randomized clinical trials (RCTs), comparative observational studies, and case series that compared maintaining factor VIII (FVIII) levels or von Willebrand factor (VWF) levels at &amp;gt;0.50 IU\/mL for at least 3 days in patients undergoing major surgery, and those with options for perioperative management of patients undergoing minor surgery. Two authors screened and abstracted data and assessed the risk of bias. We conducted meta-analyses when possible. We evaluated the certainty of the evidence using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. We included 7 case series for major surgeries and 2 RCTs and 12 case series for minor surgeries. Very-low-certainty evidence showed that maintaining FVIII levels or VWF levels of &amp;gt;0.50 IU\/mL for at least 3 consecutive days showed excellent hemostatic efficacy (as labeled by the researchers) after 74% to 100% of major surgeries. Low- to very-low-certainty evidence showed that prescribing tranexamic acid and increasing VWF levels to 0.50 IU\/mL resulted in fewer bleeding complications after minor procedures compared with increasing VWF levels to 0.50 IU\/mL alone. Given the low-quality evidence for guiding management decisions, a shared-decision model leading to individualized therapy plans will be important in patients with VWD who are undergoing surgical and invasive procedures.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005666","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T17:57:26Z","timestamp":1634752646000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9900","authenticated-orcid":false,"given":"Romina","family":"Brignardello-Petersen","sequence":"first","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"El Alayli","sequence":"additional","affiliation":[{"name":"Outcomes and Implementation Research Unit, Department of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedaa","family":"Husainat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, St. Mary\u2019s Hospital, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-4561","authenticated-orcid":false,"given":"Mohamad","family":"Kalot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, State University of New York at Buffalo, Buffalo, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaneela","family":"Shahid","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"},{"name":"Department of Pediatrics, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Aljabirii","sequence":"additional","affiliation":[{"name":"Lincoln Medical and Mental Health Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7084-7053","authenticated-orcid":false,"given":"Alec","family":"Britt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Alturkmani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"El-Khechen","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Motaghi","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-3735","authenticated-orcid":false,"given":"John","family":"Roller","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7671-9965","authenticated-orcid":false,"given":"Ahmad","family":"Dimassi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lebanese American University Medical Center, Ashrafiye, Beirut, Lebanon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-5678","authenticated-orcid":false,"given":"Omar","family":"Abughanimeh","sequence":"additional","affiliation":[{"name":"Division of Oncology and Hematology, University of Nebraska Medical Center-Fred & Pamela Buffett Cancer Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Madoukh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, State University of New York-Upstate Medical University, Syracuse, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Arapshian","sequence":"additional","affiliation":[{"name":"Middle Village, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Grow","sequence":"additional","affiliation":[{"name":"Department of Strategic Communication, Marquette University, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-8313","authenticated-orcid":false,"given":"Peter","family":"Kouides","sequence":"additional","affiliation":[{"name":"University of Rochester, Mary M. Gooley Hemophilia Treatment Center, Rochester, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-3268","authenticated-orcid":false,"given":"Michael","family":"Laffan","sequence":"additional","affiliation":[{"name":"Centre for Haematology, Imperial College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W. G.","family":"Leebeek","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-9746","authenticated-orcid":false,"given":"Sarah H.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Nationwide Children\u2019s Hospital, The Ohio State University College of Medicine, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-5204","authenticated-orcid":false,"given":"Alberto","family":"Tosetto","sequence":"additional","affiliation":[{"name":"Hematology Department, Hemophilia and Thrombosis Center, S. Bortolo Hospital, Vicenza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-9014","authenticated-orcid":false,"given":"Paula D.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-7826","authenticated-orcid":false,"given":"Nathan T.","family":"Connell","sequence":"additional","affiliation":[{"name":"Hematology Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Flood","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Wauwatosa, WI; and"},{"name":"Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-0875","authenticated-orcid":false,"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"},{"name":"Outcomes and Implementation Research Unit, Department of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"10","key":"2022010416204093900_B1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost."},{"issue":"21","key":"2022010416204093900_B2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med."},{"issue":"24","key":"2022010416204093900_B3","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.2019000510","article-title":"The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing","volume":"133","author":"Ishihara","year":"2019","journal-title":"Blood."},{"issue":"22","key":"2022010416204093900_B4","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2017-05-782029","article-title":"Advances in the diagnosis and treatment of Von Willebrand disease","volume":"130","author":"Sharma","year":"2017","journal-title":"Blood."},{"issue":"1","key":"2022010416204093900_B5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/hae.13881","article-title":"An international survey to inform priorities for new guidelines on von Willebrand disease","volume":"26","author":"Kalot","year":"2020","journal-title":"Haemophilia."},{"issue":"1","key":"2022010416204093900_B6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv."},{"issue":"9","key":"2022010416204093900_B7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2020001755","article-title":"A user guide to the American Society of Hematology clinical practice guidelines","volume":"4","author":"Izcovich","year":"2020","journal-title":"Blood Adv."},{"key":"2022010416204093900_B8","author":"French National Centre for Scientific Research (CNRS), Institut de l\u2019Information Scientifique et Technique"},{"key":"2022010416204093900_B9","author":"Cochrane Training","year":"2014"},{"key":"2022010416204093900_B10","author":"The R Foundation"},{"issue":"4","key":"2022010416204093900_B11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol."},{"key":"2022010416204093900_B12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"2022010416204093900_B13","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ."},{"issue":"12","key":"2022010416204093900_B14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"key":"2022010416204093900_B15"},{"issue":"6","key":"2022010416204093900_B16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022010416204093900_B17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2516.2010.02206.x","article-title":"Clinical efficacy and safety of the factor VIII\/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand\u2019s disease: a prospective multi-centre study","volume":"16","author":"Dunkley","year":"2010","journal-title":"Haemophilia."},{"issue":"1","key":"2022010416204093900_B18","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/hae.12497","article-title":"Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience","volume":"21","author":"Khair","year":"2015","journal-title":"Haemophilia."},{"issue":"6","key":"2022010416204093900_B19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/hae.13027","article-title":"A single-centre study of haemostatic outcomes of joint replacement in von Willebrand disease and control patients and an analysis of the literature","volume":"22","author":"Rugeri","year":"2016","journal-title":"Haemophilia."},{"issue":"2","key":"2022010416204093900_B20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/hae.13106","article-title":"Efficacy and safety of a VWF\/FVIII concentrate (wilate\u00ae) in inherited von Willebrand disease patients undergoing surgical procedures","volume":"23","author":"Srivastava","year":"2017","journal-title":"Haemophilia."},{"issue":"6","key":"2022010416204093900_B21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1160\/TH10-10-0631","article-title":"Efficacy and safety of a new generation von Willebrand factor\/factor VIII concentrate (Wilate\u00ae) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery","volume":"105","author":"Windyga","year":"2011","journal-title":"Thromb Haemost."},{"issue":"3","key":"2022010416204093900_B22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/hae.13451","article-title":"Analysis of current perioperative management with Haemate\u00ae P\/Humate P\u00ae in von Willebrand disease: identifying the need for personalized treatment","volume":"24","author":"Hazendonk","year":"2018","journal-title":"Haemophilia."},{"issue":"5809","key":"2022010416204093900_B23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bmj.2.5809.311","article-title":"Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease","volume":"2","author":"Forbes","year":"1972","journal-title":"BMJ."},{"issue":"5","key":"2022010416204093900_B24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2141.1971.tb07061.x","article-title":"Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial","volume":"20","author":"Walsh","year":"1971","journal-title":"Br J Haematol."},{"key":"2022010416204093900_B25","first-page":"133","article-title":"Surgery in adults with congenital coagulation deficiencies: how do we do it?","volume":"81","author":"Andoljsek","year":"2012","journal-title":"Zdr Vestn."},{"issue":"5","key":"2022010416204093900_B26","first-page":"235","article-title":"Hemostasis in patients at high hemorrhagic risk [in Italian]","volume":"44","author":"Franchi","year":"1995","journal-title":"Minerva Stomatol."},{"issue":"1","key":"2022010416204093900_B27","doi-asserted-by":"crossref","first-page":"e2013004","DOI":"10.4084\/mjhid.2013.004","article-title":"Circumcision in males with bleeding disorders","volume":"5","author":"Mansouritorghabeh","year":"2013","journal-title":"Mediterr J Hematol Infect Dis."},{"issue":"2","key":"2022010416204093900_B28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2516.2007.01616.x","article-title":"Efficacy of factor VIII\/von Willebrand factor concentrate alphanate in preventing excessive bleeding during surgery in subjects with von Willebrand disease","volume":"14","author":"Rivard","year":"2008","journal-title":"Haemophilia."},{"issue":"2","key":"2022010416204093900_B29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2516.2009.02119.x","article-title":"To circumcise or not to circumcise? Circumcision in patients with bleeding disorders","volume":"16","author":"Rodriguez","year":"2010","journal-title":"Haemophilia."},{"issue":"5","key":"2022010416204093900_B30","first-page":"298","article-title":"Experience with Haemate P in von Willebrand\u2019s disease in adults","volume":"24","author":"Scharrer","year":"1994","journal-title":"Haemostasis."},{"issue":"2","key":"2022010416204093900_B31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.20263","article-title":"A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: is it safe and useful?","volume":"78","author":"Shin","year":"2005","journal-title":"Am J Hematol."},{"issue":"9","key":"2022010416204093900_B32","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1111\/j.1572-0241.2000.02338.x","article-title":"Liver biopsies in adult hemophiliacs with hepatitis C: a United States center\u2019s experience","volume":"95","author":"Venkataramani","year":"2000","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2022010416204093900_B33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2516.2008.01755.x","article-title":"Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI","volume":"14","author":"Viswabandya","year":"2008","journal-title":"Haemophilia."},{"issue":"4","key":"2022010416204093900_B34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/hae.12146","article-title":"Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study","volume":"19","author":"Davis","year":"2013","journal-title":"Haemophilia."},{"issue":"1","key":"2022010416204093900_B35","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1111\/j.1365-2516.2010.02346.x","article-title":"Dental surgery with minimal factor support in the inherited bleeding disorder population at the Alfred Hospital","volume":"17","author":"Hewson","year":"2011","journal-title":"Haemophilia."},{"issue":"7-8","key":"2022010416204093900_B36","first-page":"488","article-title":"Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation","volume":"128","author":"Lewandowski","year":"2018","journal-title":"Pol Arch Intern Med."},{"issue":"5809","key":"2022010416204093900_B37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/bmj.2.5809.314","article-title":"Use of tranexamic acid in control of haemorrhage after extraction of teeth in haemophilia and Christmas disease","volume":"2","author":"Tavenner","year":"1972","journal-title":"BMJ."},{"key":"2022010416204093900_B38","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2021005589","article-title":"Gynecologic and obstetric management of women with von Willebrand disease: summary of three systematic reviews of the literature","author":"Brignardello-Petersen","year":"2021"},{"key":"2022010416204093900_B39","article-title":"Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: a systematic literature review","author":"Brignardello-Petersen","year":"2021"},{"issue":"6","key":"2022010416204093900_B40","doi-asserted-by":"crossref","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/121\/1856728\/advancesadv2021005666c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/121\/1856728\/advancesadv2021005666c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T12:09:49Z","timestamp":1699704589000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/1\/121\/477340\/Surgical-management-of-patients-with-von"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005666","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}